RVMD is trading 4.4% up at $190.08 after several bullish analyst actions raised price targets and reaffirmed Buy ratings.
- The stock is extending its recent run to all-time highs as investors respond to upgraded revenue forecasts.
- Market sentiment remains high due to ongoing enthusiasm for the company's RAS-targeted oncology pipeline.